A strategic location

The Paris Region benefits from a central position in Western Europe with easy access to other big cities by train or plane. It boasts French academic excellence with leading universities such as Paris Saclay University (1st worldwide in mathematics), Sorbonne, and PSL.
In the last years, the region has been leading the attractivity for Foreign Direct Investments in R&D and corporate investments (Global Cities Investment Monitor 2022).

#1 Worlwide for FDI in R&D and corporate projects.
 

A strong network of clusters and communities

Startups inside the Paris Region benefit from the expertise of many clusters that are directly related to the health industry such as:

Genopole, a scientific campus & business cluster for biotechnologies located in the south of Paris in Evry Courcouronnes. The Genopole is the main cluster for genomics with companies developing Cell & Gene Therapies, diagnostic solutions, foodtech, and more. It currently hosts 70+ companies and 16 academic laboratories.

The Paris Saclay Cancer Cluster, one of the 1st projects supported by France 2030 aims to support innovation in oncology by making it more predictive, precise, and efficient. By bringing together all these skills in a single location, the PSCC creates a patient-centric ecosystem to establish a leading hub in the field of oncology.

Paris Saclay Research and Innovation Cluster. Paris Saclay has been ranked in the top 8 innovation clusters in the world. It benefits from a strong biopharma ecosystem with companies like Servier, Merck, and Ipsen operating in the area. It will also benefit from new infrastructures willing to accelerate biotech startup development with Kadans and Biolabs.

Medicen brings together private and public organizations around innovation to develop the therapeutic solution of the future. It acts as a unifier for the whole ecosystem and accounts for more than 500 members including 430 startups.

Brain&Mind is the Greater Paris Neursocience cluster, it aims to bring together all key actors in neuroscience to favor innovation in neurology (Parkinson, Alzheimer, ALS, etc), mental health ( Autism, Schizophrenia, Depression), and sensory disorders (Vision, Audition).

A dynamic startups Scene

We count more than 12,000 startups inside the Paris Region, and when it comes to funding, the Paris-region-based startups attract around 70% of the total amount raised in France. For Healthcare, in the past three years, Paris Region healthcare companies raised more than €3Bn.
Foreign startups can also find a large offer of incubators dedicated to HealthTech:

• Therapeutic Area focused: (Ipeps, Springobard)
• With lab spaces: (Biolabs, Paris Biotech Santé, Genopole)
• Focused on Digital Health: (Future4Care, PariSanté Campus)
• Multi sector: (Wilco, Agoranov, Station F)

A research Powerhouse

With 21,3Bn euros in R&D expenditures, the Paris region is the 1st region in Europe for R&D expenses. All companies conducting research in France can benefit from a 30% tax credit on their R&D expenses.

When it comes to healthcare research, the region benefits from multiple key assets: Paris Region has Europe’s largest hospital network, Assistance Publique Hopitaux de Paris (AP-HP), which treats more than 8 million patients every year. There are currently 12,000 doctors and 4,500 sponsored research projects in progress. The APHP includes two of the best hospitals in the world, according to Newsweek, Hôpital Universitaire Pitié Salpêtrière and Hôpital Européen Georges Pompidou.

Besides APHP, Paris Region counts numerous research centers leading the way in their respective fields to advance medical technology and knowledge. Here are a few of them based on their expertise areas:

Oncology: Curie, Gustave Roussy;
Neuroscience: ICM, Fondamental, Vision Institute;
Rare and Genetic diseases: Genethon, Imagine;
Metabolism: ICAN;
Infectious Diseases: Pasteur.

Digital Health

One of the key components of the plan “Innovation Santé 2030” is to position France as a world leader in digital health.

This strategy aims to facilitate the development of innovative solutions backed by scientific approaches to conquer a booming digital health market.

Many laws and incentives have been started to encourage this development like the reimbursement of telesurveillance activities or the PECAN program (fast-track reimbursement pathway) for DTx and digital medical devices.

In the Paris Region, many initiatives emerged from that strategy including:

Paris Santé Campus, the flagship project for tomorrow’s e-health in France. With a current surface of 15,000 m², it welcomes all the innovative stakeholders in digital health and aims to gather researchers, caregivers, entrepreneurs, institutions, and citizens.

Future4Care, is a corporate accelerator that offers a dedicated 360 and personalized support to digital health companies. With 6,400m² of office spaces in Paris, the accelerator has the perfect program to help you scale your solution and industrialize it.

The French Health Innovation Plan also launched new places to test digital solutions directly in real life settings, the Paris Region counts 9 of those:

• D4MedTech (Diabetes)
• Hotel Dieu (Digital Health)
• Interception (Diagnostic and prevention)
• Novavue (Vision)
• Holistic (AI)
• Unirein (Kidney and metabolic disease)
• Santinel (Imaging)
• Bopex (Surgery)
• Mindlink (Mental Health)

Network and Find Investors (HealthTech events in Paris Region)

SANTEXPO, Paris, May - This annual event gathers the entire health ecosystem: equipment manufacturers, software editors, suppliers, e-health entrepreneurs, medical device manufacturers, decision-makers, and health professionals involved in the management, digital, equipment, and construction of health facilities

Medintechs, Paris, March - Medintechs is an exhibition bringing together the general public, patient associations, federations, health professionals, and experts in new technologies. The aim of the exhibition is to highlight the latest innovations, to make them accessible, but also to enable the general public to find out how to take control of their health.

HealthTech Innovation Days, Paris, October - This event intends to make Paris the European capital for health innovation to accelerate care access for all patients. With more than 150 healthtech companies, and more than 300 international investors, these days are the perfect occasion to create partnerships, meet investors and learn about trendy subjects in order to make the health ecosystem evolve.

VivaTechnology, Paris, June: VivaTech accelerates innovation by connecting startups, tech leaders, major corporations, and investors responding to our world’s biggest challenges. It is considered the biggest tech event in the world with around 165,000 visitors each year and 13,500 startups.

Congrès France Bioproduction: The “Congrès France Bioproduction” is the annual meeting of the biomanufacturing ecosystem in France, it federates all actors of the industry (CDMO,s CROs, OEM Manufacturers, Biotech, Pharma, etc). It is organized by PolePharma and Medicen, the two main clusters for Healthtech and Pharma in Paris Region.

Explore the Healthech Paris Region Map

Success Stories

Infocus Therapeutics Choose Paris Region for its First European Expansion
InFocus Therapeutics is a next-generation biotechnology company that redefines RNA-targeted drug discovery through artificial intelligence and molecular innovation.
Headquartered in Cambridge, Massachusetts, and now established within the Paris-Saclay Cancer Cluster (PSCC), the company is pioneering a new class of RNA-targeted small molecule therapeutics designed to restore gene function in complex diseases such as cancer and neurodegenerative disorders.
Read more

Aiforia launches its AI hub in Paris Region
Founded in 2013, Aiforia is a pioneering healthtech company transforming medical imaging through artificial intelligence and deep learning.
Aiforia’s decision to establish its first European hub outside the Nordics in Paris Region marks a strategic milestone in its international growth. By joining one of Europe’s most dynamic life sciences ecosystems — home to leading research institutions, global biopharma companies, and top AI talent — the company is strengthening its presence on the continent and reinforcing its R&D capabilities.
Read more

Shaping Tomorrow's Labs: Kadans Science Partner's Journey in Europe
We recently sat down with Eliane Benaroya, Chief of Staff at Actipulse Neuroscience, to discuss their groundbreaking work in non-invasive brain stimulation technologies to facilitate drug delivery to the brain. Settled in France in 2023, this Mexico-rooted company is at the forefront of neuromodulation, leveraging cutting-edge technology to enhance drug delivery to the brain by transiently opening the Blood-Brain Barrier (BBB). Join us as Eliane delves into Actipulse’s innovative approach, their strategic expansion into Paris Region, and the future of CNS treatment.
Read more